Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1132981

	registered interest
	date	18/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Legal Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 June 2019 to Question 263752 on NHS: Legal Costs, how much was money was spent by (a) NHS England, (b) NHS trusts, (c) Health Education England and (d) NHS Improvement on the services of (a) Bevan Brittan, (b) Mills & Reeve, (c) DAC Beechcroft, (d) Hempsons, (e) Capsticks and (f) Hill Dickinson in relation to employment disputes in each of the last five years.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	266123
	answer	answer is ministerial correction date of answer 24/06/2019 answer text <p>The arm’s length bodies concerned do not collect information in the format requested. The transactions charged by the organisations involved do not specifically itemise legal costs as ‘employment disputes’.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/06/2019 15:28:59 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1439 label Biography information for Norman Lamb

1135293

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Legal Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 June 2019 to Question 266123 on NHS: Legal Costs, how his Department differentiates between individual projects or cases; and what steps his Department takes to (a) ensure that public funds paid to those legal services providers is in respect of work actually done or carried out by those providers and (b) record the areas of law and jurisdictions of courts and tribunals in which the work is done.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	270315
	answer	answer is ministerial correction date of answer 02/07/2019 answer text <p>The Department uses two main routes to engaging legal support.</p><p>- The Department’s Anti-Fraud Unit (AFU) engages external law firms through the Civil Litigation and Arbitration in Medicines and Pharmaceuticals Framework, as well as the Government Legal Department (GLD). The AFU utilises a case management system in order to differentiate between individual cases and checks are conducted against invoices and supporting documents submitted by each law firm, including GLD, to ensure these are reflective of their instructions.</p><p> </p><p>- Other business areas within the Department consult with the GLD on the resources available and should they not have the capacity then they will a conduct a competition for other Legal service providers using the Crown Commercial Services framework contract. GLD will ensure that deliverables are agreed and undertaken to the agreed quality before payments are made.</p><p> </p><p> </p><p> </p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 02/07/2019 16:11:28 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1439 label Biography information for Norman Lamb

1138829

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to improve support for people with neurodevelopmental conditions.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	277125
	answer	answer is ministerial correction date of answer 18/07/2019 answer text <p>The Government is committed to supporting people with neurodevelopmental conditions to live well. We are currently reviewing the adult autism strategy and working with the Department of Education will be extending the scope of the strategy to include children. The refreshed strategy will be published by the end of the year. We are also working closely with the National Institute for Health and Care Excellence (NICE) and their attention deficit hypersensitivity disorder (ADHD) Implementation Working Group to look at how the current NICE guidance and quality standard on ADHD are being implemented. This work includes looking to identify best practice and examples of innovation, which have improved outcomes for people with ADHD, so that these can be widely disseminated to commissioners to improve local practice. We are considering what actions can be taken to support those with other neurodevelopmental conditions.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 18/07/2019 09:28:06 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1439 label Biography information for Norman Lamb

1147165

	registered interest
	date	30/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Chief Scientific Advisers
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many meetings he had with his Department’s Chief Scientific Adviser from 1 June to 31 August 2019.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	292148
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>For the period 1 June 2019 to 31 August 2019 my Rt. Hon. Friend the Secretary of State for Health and Social Care met with the Department’s Chief Scientific Adviser (CSA) three times, the CSA met with other Health Ministers on seven occasions.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 08/10/2019 10:30:10 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1439 label Biography information for Norman Lamb

1149333

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether anti-epileptic drugs are exempted from serious shortage protocols; and what assessment he has made of the potential effect of the use of such protocols on (a) people with learning disabilities and (b) their families in the event that the UK leaves the EU without a withdrawal agreement.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	475
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>While Serious Shortage Protocols (SSP) in England have the scope to cover all medicines and appliances that are on a National Health Service prescription in primary care, including anti-epileptic drugs, it is clear that an SSP for therapeutic or generic equivalents will not necessarily be suitable for all medicines and patients. For example, where medicines need to be prescribed by brand for clinical reasons, which is the case for epilepsy medication.</p><p>Any protocol would only be introduced if clinicians with expertise in the relevant area think it is appropriate. Pharmacists will have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate or the patient should be referred to their prescriber.</p><p>The legislation enabling Ministers to issue SSPs was not introduced as a European Union exit measure alone but as a business-as-usual measure that can be used before and after our exit from the EU.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 13:07:33 answering member 4362 label Biography information for Edward Argar
	tabling member	1439 label Biography information for Norman Lamb

1149339

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of anti-epilepsy medications in the event that the UK leaves the EU without a deal.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	479
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including those used for the treatment of epilepsy, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We have been working closely with suppliers to monitor over 300 different epilepsy medicines provided by almost 50 companies and we are pleased to see many are holding stockpiles far beyond the six weeks’ additional buffer we requested. We also know that the vast majority of those suppliers with lower levels of stockpiles are taking action to re-route their supply chains away from the short straits crossings where applicable.</p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 13:04:06 answering member 4362 label Biography information for Edward Argar
	tabling member	1439 label Biography information for Norman Lamb

1150324

	registered interest
	date	17/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a withdrawal agreement.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	1607
	answer	answer is ministerial correction date of answer 22/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p>The Department, as part of our EU exit preparations, has analysed the supply chains of over 12,000 licensed medicines used by patients in the United Kingdom and close to half a million product lines of medical devices and clinical consumables with an EU/European Economic Area touchpoint. This approach means that the medicines and medical equipment used by people living with disabilities are included within our planning.</p><p>We continue to implement a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/10/2019 15:31:09 answering member 4362 label Biography information for Edward Argar
	tabling member	1439 label Biography information for Norman Lamb

1143605

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial in BAME communities.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	285065
	answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 285069 question first answered 05/09/2019 15:28:31 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb

1143606

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial amongst women at high risk of contracting HIV.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	285069
	answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 285065 question first answered 05/09/2019 15:28:31 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb

1166900

	registered interest
	date	28/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to fulfill its commitment in its Prevention Green Paper to seek views on how to improve the healthy social and emotional development of babies and young children.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	6261
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>The Government is taking steps to fulfil its commitment in its Prevention Green Paper to seek views on how to improve the healthy social and emotional development of babies and young children.</p><p>Public Health England’s (PHE’s) vision is to improve the health of babies, children and their families and to enable the foundations of good health into adulthood. A large proportion of this work will be done through the modernisation of the Healthy Child Programme, which is PHE’s national offer to our children and families. This can be viewed at the following links:</p><p> </p><p><a href="https://www.gov.uk/government/publications/healthy-child-programme-pregnancy-and-the-first-5-years-of-life" target="_blank">https://www.gov.uk/government/publications/healthy-child-programme-pregnancy-and-the-first-5-years-of-life</a></p><p><a href="https://www.gov.uk/government/publications/healthy-child-programme-5-to-19-years-old" target="_blank">https://www.gov.uk/government/publications/healthy-child-programme-5-to-19-years-old</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2019 12:02:19 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb